http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104774928-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2015-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104774928-B |
| titleOfInvention | The application of people's RRS1 genes and inhibitor |
| abstract | The present invention relates to biotechnologies, disclose application and inhibitor of the people RRS1 genes in screening tumor therapeutic agent, preparation tumor therapeutic agent or preparation cancer diagnosis drug.The present invention is using people RRS1 genes as target, by choosing suitable target-gene sequence, it is designed in such a way that RNA is interfered with the expression for efficiently inhibiting RRS1 genes, and the inhibitor such as nucleic acid molecules, recombinant vector and slow virus for effectively inhibiting the human tumor cells especially proliferation of colon cancer tumours cell, application of the people RRS1 genes in screening tumor therapeutic agent, preparation tumor therapeutic agent or preparation cancer diagnosis drug is provided, oncotherapy approach is enriched. |
| priorityDate | 2015-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.